GLP-1s for Polyendocrine Metabolic Ovarian Syndrome Women with polyendocrine metabolic ovarian syndrome (PMOS) produce excess testosterone, which can lead to painful, heavy, or irregular periods, infertility, excess facial and body hair, severe acne, and small cysts on the ovaries
Once activated, ERK1/2 is transferred to the nucleus, where it phosphorylates transcription factors such as c-Myc and c-Fos, leading to the expression of genes responsible for cellular regulations such as cell proliferation, differentiation, and migration
At steady-state, histological examination did not reveal major macroscopic anomalies in the follicle architecture of mutant animals (Fig
By the numbers: The Wegovy pill is available to eligible patients with a range of affordability options